LTG-321 — Topline data
H2 2027
Expect to report topline results from the Phase 2 clinical trial in the second half of 2027.Source filing
LTGO biotech catalysts & pipeline
LATIGO BIOTHERAPEUTICS INC · Data as of 2026-09-08
Upcoming catalysts
onzotrigine — Topline data
H2 2027
Expect to report topline results from the Phase 3 bunionectomy and open-label safety clinical trials in the second half of 2027.Source filing